Lepu Medical Technology Beijing Co Ltd: A Comprehensive Overview

Lepu Medical Technology (Beijing) Co., Ltd., a prominent player in the health care equipment and supplies sector, continues to make significant strides in the medical device industry. With a diverse portfolio that spans cardiovascular interventional products, surgical cardiology, and precision medicine, Lepu Medical is at the forefront of innovation in China and beyond.

Market Position and Financial Health

As of June 12, 2025, Lepu Medical’s stock closed at 12.79 CNY on the Shenzhen Stock Exchange, reflecting a market capitalization of approximately 24.6 billion CNY. Despite a challenging year, the company’s stock has shown resilience, with a 52-week high of 16.26 CNY and a low of 9.01 CNY. The price-to-earnings ratio stands at 159.127, indicating investor confidence in the company’s long-term growth potential.

Product Portfolio and Innovations

Lepu Medical’s product offerings are extensive and cater to a wide range of medical needs. The company specializes in cardiovascular interventional products, including coronary stents, balloons, catheters, and PCI accessories. Their surgical cardiology products, such as off-pump coronary artery bypass grafting devices, are complemented by peripheral interventional products like PTA balloons and guide wires.

In the realm of structural heart diseases, Lepu Medical provides occluders, vascular plugs, delivery systems, and mechanical heart valves. Their cardiac rhythm management products, including pacemakers and leads, are critical in managing arrhythmias. Additionally, the company offers critical care products, such as vascular access products and needle-free connectors, alongside floor and suspended type digital subtraction angiography systems.

Lepu Medical’s in vitro diagnostic (IVD) products, dialysis products, and general surgery products further underscore their comprehensive approach to healthcare solutions. The company’s pharmaceutical offerings include cardiovascular system drugs, antimicrobial drugs, central nervous system drugs, digestive system drugs, respiratory system drugs, and hypoproteinemia drugs.

Strategic Services and Future Outlook

Beyond products, Lepu Medical is committed to advancing healthcare through precision medicine, ECG telemonitoring, and cardiovascular disease consulting and management centers. Their medical S&T incubation and equity investment initiatives, along with medical financial services, health consultation, online pharmacy, and household medical equipment services, position them as a holistic healthcare provider.

Founded in 1999 and headquartered in Beijing, Lepu Medical has grown significantly since its IPO on October 30, 2009. As the company continues to innovate and expand its global footprint, it remains a key player in the health care equipment and supplies industry.

For more information, visit Lepu Medical’s website .

This article provides a comprehensive overview of Lepu Medical Technology Beijing Co Ltd, highlighting its market position, product portfolio, and strategic services. With a forward-looking perspective, Lepu Medical is poised for continued growth and innovation in the healthcare sector.